ASEAN Cosmetic Directive: shared annexes, national notification — 2025–26 still works that way
ACSB annex updates only become “your problem” when a Member State issues a circular. Budget ten front doors, not one ASEAN certificate.
Registration
China cosmetics GMP lift plan (2026–2028): expect more on-site questions, not a new ISO number
NMPA told provincial regulators to run a three-year quality-system improvement action. Manufacturers in China should expect deeper file-vs-floor checks.
China NMPA reform opinions (17 Nov 2025): a 2030 roadmap, not a filing instruction
NMPA’s 24-measure reform opinion sets a 2030 destination. Use it to understand why 2026 announcements exist — do not file against a white paper.
China NMPA consulted the cosmetics reform opinion through 10 October 2025
The September 2025 consultation was the draft of the November opinion. Useful as timeline context; the November text is what you keep.
EU CPNP and Responsible Person: the unglamorous duties that still stop first shipments
Article 4 and Article 13 duties did not change in 2025. They still cause more failed first shipments than annex chemistry.
Korea Cosmetics Act 2025–26: overseas direct purchase plus a multi-year safety-assessment path
Korea tightened Cosmetics Act tools for overseas direct-purchase goods and signalled a staged safety-assessment duty toward 2028–2031. This is a Korea-local project, not an EU CPSR paste.